Skip to main content

Psoriasis and Pityriasis Rubra Pilaris

  • Chapter
  • First Online:
Severe Skin Diseases in Children

Abstract

Psoriasis and pityriasis rubra pilaris (PRP) are both chronic skin disorders characterized by well-demarcated, scaly papules and plaques. Lesions can range from few and circumscribed to diffuse and distressing. Although psoriasis is more common with known comorbidities, PRP likely places a similar psychological burden on patients. The two conditions, their features, and management, particularly the use of systemic therapies, will be discussed here.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Klein A, Landthaler M, Karrer S. Pityriasis rubra pilaris: a review of diagnosis and treatment. Am J Clin Dermatol. 2010;11(3):157–70.

    Article  PubMed  Google Scholar 

  2. Schon MP, Boehncke W-H. Psoriasis. N Engl J Med. 2005;352(18):1899–912.

    Article  PubMed  CAS  Google Scholar 

  3. Kwon HH, Na SJ, Jo SJ, Youn JI. Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic. J Dermatol. 2012;39(3):260–4.

    Article  PubMed  Google Scholar 

  4. Silverberg NB. Psoriasis: an update. Ther Clin Risk Manag. 2009;5:849–56.

    Article  PubMed  CAS  Google Scholar 

  5. Albert MR, Mackool BT. Pityriasis rubra pilaris. Int J Dermatol. 1999;38:1–11.

    Article  PubMed  CAS  Google Scholar 

  6. Allison DS, Et Azhary RA, Caloprisi SD. Pityriasis rubra pilaris in children. J Am Acad Dermatol. 2002;47:386–9.

    Article  PubMed  Google Scholar 

  7. Dhar S, Banerjee R, Agrawal N, Chatterjee S. Psoriasis in children: an insight. Indian J Dermatol. 2011;56(3):262–5.

    Article  PubMed  Google Scholar 

  8. Gottlieb AB, Chaudhari U, Baker DG, Perate M, Dooley LT. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician’s Global Assessment (PGA): a comparison. J Drugs Dermatol. 2003;2(3):260–6.

    PubMed  Google Scholar 

  9. Bhutani T, Kamangar F, Cordoro KM. Management of pediatric psoriasis. Pediatr Ann. 2012;41(1):e1–7.

    PubMed  Google Scholar 

  10. Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol. 2001;18(3):188–98.

    Article  PubMed  CAS  Google Scholar 

  11. Roberson ED, Bowcock AM. Psoriasis genetics: breaking the barrier. Trends Genet. 2008;26(9):415–23.

    Article  Google Scholar 

  12. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol. 2007;25(6):606–15.

    Article  PubMed  Google Scholar 

  13. Tollefson MM, Crowson CS, McEvoy MT, Kremers HM. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010;62(6):979–87.

    Article  PubMed  Google Scholar 

  14. Teran CG, Teran-Escalera CN, Balderrama C. A severe case of erythrodermic psoriasis associated with advanced nail and joint manifestations: a case report. J Med Case Reports. 2010;4:179.

    Article  Google Scholar 

  15. Chao PH, Cheng YW, Chung MY. Generalized pustular psoriasis in a 6-week-old infant. Pediatr Dermatol. 2009;26(3):352–4.

    Article  PubMed  Google Scholar 

  16. Stoll ML, Punaro M. Psoriatic juvenile idiopathic arthritis: a tale of two subgroups. Curr Opin Rheumatol. 2011;23:437–43.

    Article  PubMed  Google Scholar 

  17. Paller AS, Siegfried EC, Langley RG, Gottlieb AB, Pariser D, Landells I, Herbert AA, Eichenfield LF, Patel V, Creamer K, Jahreis A. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl J Med. 2008;358(3):241–51.

    Article  PubMed  CAS  Google Scholar 

  18. Busch AL, Landau JM, Moody MN, Goldberg LH. Pediatric psoriasis. Skin Therapy Lett. 2012;17(1):4–7.

    Google Scholar 

  19. Stahle M, Atakan N, Boehncke W, Chimenti S, Daudens E, Giannetti A. Juvenile psoriasis and its clinical management: a European expert group consensus. J Dtsch Dermatol Ges. 2010;8:812–8.

    PubMed  Google Scholar 

  20. Tay YK, Morelli JG, Weston WL. Experience with UVB phototherapy in children. Pediatr Dermatol. 1996;13(5):406–9.

    Article  PubMed  CAS  Google Scholar 

  21. de Jager ME, de Jong EM, van de Kerkhof PC, Seyger MM. Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol. 2010;62(6):1013–30.

    Article  PubMed  Google Scholar 

  22. Cordoro KM. Systemic and light therapies for the management of childhood psoriasis: part II. Skin Therapy Lett. 2008;13(4):1–3.

    Google Scholar 

  23. Mahe E, Bodemer C, Pruszkowski A, Teillac-Hamel D, de Prost Y. Cyclosporine in childhood psoriasis. Arch Dermatol. 2001;137:1532–3.

    PubMed  CAS  Google Scholar 

  24. Hoefnagel JJ, Thio HB, Willemeze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol. 2003;149:363–9.

    Article  PubMed  CAS  Google Scholar 

  25. Klein A, Coras B, Landthaler M, Babilas P. Off-label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study. J Eur Acad Dermatol Venereol. 2011;18:e1–7.

    Google Scholar 

  26. Marji JS, Marcus R, Moennich J, Mackay J. Use of biologic agents in pediatric psoriasis. J Drugs Dermatol. 2010;9(8):975–86.

    PubMed  Google Scholar 

  27. Alwawi EA, Krulig E, Gordon KB. Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? Dermatol Ther. 2009;22(5):431–40.

    Article  PubMed  Google Scholar 

  28. Siegfried EC, Eichenfield LF, Paller AS, Pariser D, Creamer K, Kricorian G. Intermittent etanercept therapy in pediatric patients with psoriasis. J Am Acad Dermatol. 2010;63(5):769–74.

    Article  PubMed  CAS  Google Scholar 

  29. Menter A, Gordon KB, Leonardi CL, Gu Y, Goldblum OM. Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis. J Am Acad Dermatol. 2010;63(3):448–56.

    Article  PubMed  CAS  Google Scholar 

  30. Magro CM, Crowson AN. The clinical and histomorphological features of pityriasis rubra pilaris. A comparative analysis with psoriasis. J Cutan Pathol. 1997;24(7):416–24.

    Article  PubMed  CAS  Google Scholar 

  31. Sehgal VN, Srivastava G. (Juvenile). Pityriasis rubra pilaris. Int J Dermatol. 2006;45:438–46.

    Google Scholar 

  32. Gelmetti C, Schiuma AA, Cerri D, Gianotti F. Pityriasis rubra pilaris in childhood: a long-term study of 29 cases. Pediatr Dermatol. 1986;3(6):446–51.

    Article  PubMed  CAS  Google Scholar 

  33. Yang CC, Shih IH, Lin WL, Yu YS, Chiu HC, Huang PH, Cheng YW, Lee JY, Chen W. Juvenile pityriasis rubra pilaris: report of 28 cases in Taiwan. J Am Acad Dermatol. 2008;59(6):943–8.

    Article  PubMed  Google Scholar 

  34. Fung YP. Pityriasis rubra pilaris: an update review. Hong Kong J Dermatol. 2001;9(1):10–6.

    Google Scholar 

  35. Möhrenschlager M, Abeck D. Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): report of two new cases. Pediatr Dermatol. 2002;19(6):569.

    Article  PubMed  Google Scholar 

  36. Wetzig T, Sticherling M. Juvenile pityriasis rubra pilaris: successful treatment with ciclosporin. Br J Dermatol. 2003;149(1):202–3.

    Article  PubMed  CAS  Google Scholar 

  37. Cox V, Lesesky EB, Garcia BD, O’Grady TC. Treatment of juvenile pityriasis rubra pilaris with etanercept. J Am Acad Dermatol. 2008;59(5 Suppl):S113–4.

    Article  PubMed  Google Scholar 

  38. Ivanova K, Itin P, Haeusermann P. Pityriasis rubra pilaris: treatment with biologics - a new promising therapy? Dermatology. 2012;224(2):120–5.

    Article  PubMed  Google Scholar 

  39. Gómez M, Ruelas ME, Welsh O, Arcaute HD, Ocampo-Candiani J. Clinical improvement of pityriasis rubra pilaris with efalizumab in a pediatric patient. J Drugs Dermatol. 2007;6(3):337–9.

    PubMed  Google Scholar 

  40. Ruzzetti M, Saraceno R, Carboni I, Papoutsaki M, Chimenti S. Type III juvenile pityriasis rubra pilaris: a successful treatment with infliximab. J Eur Acad Dermatol Venereol. 2008;22(1):117–8.

    PubMed  CAS  Google Scholar 

  41. Schreml S, Zeller V, Babilas P, Karrer S, Landthaler M, Szeimies RM. Pityriasis rubra pilaris successfully treated with adalimumab. Clin Exp Dermatol. 2010;35(7):792–3.

    Article  PubMed  CAS  Google Scholar 

  42. Kumar B, Dhar S, Handa S, Kaur I. Methotrexate in childhood psoriasis. Pediatr Dermatol. 1994;11(3):271–3.

    Article  PubMed  CAS  Google Scholar 

  43. Vasher M, Smithberger E, Lien MH, Fenske NA. Familial pityriasis rubra pilaris: report of a family and therapeutic response to etanercept. J Drugs Dermatol. 2010;9(7):844–50.

    PubMed  Google Scholar 

  44. Kerensky TA, Gottlieb AB, Yaniv S, Au SC. Etanercept: efficacy and safety for approved indications. Expert Opin Drug Saf. 2012;11(1):121–39.

    Article  PubMed  CAS  Google Scholar 

  45. Iervolino S, Lofrano M, Di Minno MN, Foglia F, Scarpa R, Peluso R. IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report. Reumatismo. 2012;64(1):40–3.

    Article  PubMed  CAS  Google Scholar 

  46. Kimball AB, Wu EQ, Guerin A, Yu AP, Tsaneva M, Gupta SR, Bao Y, Mulani PM. Risks of developing psychiatric disorders in pediatric patients with psoriasis. J Am Acad Dermatol. 2012;12:e1–9.

    Google Scholar 

  47. Kimball AB, Gieler U, Linder D, Sampogna F, Warren RB, Augustin M. Psoriasis: is the impairment to a patient’s life cumulative?. J Eur Acad Dermatol Venereol (JEADV). 2010;24(9):989–1004.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adelaide A. Hebert MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pacha, O., Schlichte, M.J., Hebert, A.A. (2014). Psoriasis and Pityriasis Rubra Pilaris. In: Tom, W. (eds) Severe Skin Diseases in Children. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39532-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39532-1_2

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39531-4

  • Online ISBN: 978-3-642-39532-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics